About The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
During the past decade, The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto
2002-11-01
2005-11-01
Completed
15
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
2006-03-01
2012-03-01
Completed
203
Sentinel Lymph Node Technique in Multifocal Breast Cancer
2006-03-01
2008-09-01
Completed
216
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
2004-05-01
2011-01-01
Completed
Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix
2007-04-01
2008-09-01
Terminated
44
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
2010-07-01
2020-12-31
Completed
408
Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects
2005-08-01
2016-01-01
Completed
490
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham" #1 sponsor was "C. R. Bard" with 1 trials, followed by "CHDI Foundation, Inc." with 1 trials
sponsored, "Eisai Inc." with 1 trials sponsored, "Naurex, Inc, an affiliate of Allergan plc" with 1 trials sponsored and "Rutgers, The State University of New Jersey"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham"
#1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "University of Alabama at Birmingham" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
According to Clinical.Site data, the most researched conditions in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham" are
"Arteriovenous Fistula" (1 trials), "Atherosclerosis" (1 trials), "Carotid Stenosis" (1 trials), "Cerebral Infarction" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham" in a lesser frequency.
Clinical Trials Intervention Types at The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
Most popular intervention types in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham" are "Device" (2 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carotid Artery Stenting (CAS)" (1 trials), "Carotid Endarterectomy (CEA)" (1 trials), "Lutonix DCB" (1 trials), "Perampanel" (1 trials) and "Percutaneous Transluminal Angiography" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
The vast majority of trials in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham" are
5 trials for "All" genders.
Clinical Trials Status at The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham
Currently, there are NaN active trials in "The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".